PRospective Evaluation of Interstitial Lung DIsease Progression With Quantitative CT
Condition(s):Interstitial Lung DiseaseLast Updated:November 8, 2022Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Interstitial Lung DiseaseLast Updated:November 8, 2022Not yet recruiting
Condition(s):Granulomatous and Lymphocytic Interstitial Lung DiseaseLast Updated:March 10, 2020Withdrawn
Condition(s):Interstitial Lung DiseaseLast Updated:December 14, 2023Active, not recruiting
Condition(s):Rheumatoid Arthritis; Interstitial Lung DiseaseLast Updated:June 6, 2019Unknown status
Condition(s):Pulmonary DiseaseLast Updated:October 26, 2023Active, not recruiting
Condition(s):Interstitial Lung Disease (ILD)Last Updated:December 7, 2020Completed
Condition(s):Chronic Obstructive Pulmonary DiseaseLast Updated:April 23, 2019Unknown status
Condition(s):Interstitial Lung Disease; Idiopathic Pulmonary FibrosisLast Updated:November 18, 2023Completed
Condition(s):Interstitial Lung DiseaseLast Updated:April 6, 2022Completed
Condition(s):Microbiome; Immune Function; Anti-MDA5 Antibody Positive DermatomyositisLast Updated:January 12, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.